Code | 2516D | ||||||||||
MA number | 31/0295/19-S | ||||||||||
Product Form: | tbl 30x10 mg/80 mg (blis.OPA/Al/PVC) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | Zentiva, k.s., Czechia | ||||||||||
Therapeutic Class: | 31 - HYPOLIPIDAEMICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Container: | blister OPA/Al/PVC | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10b fixed combination application |
MA issued: | 26.09.2019 |
PIL: | PIL_Zetovar tablety_02.2024.pdf |
SPC: | SPC_Zetovar tablety_02.2024.pdf |
Safety feature | Yes |
Data update: | 15.04.2024 |